Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q3720273> ?p ?o }
Showing triples 1 to 26 of
26
with 100 triples per page.
- Q3720273 subject Q7444591.
- Q3720273 abstract "Efungumab (trade name Mycograb) is a drug developed by NeuTec Pharma (a subsidiary of Novartis), intended to treat invasive Candida infection in combination with amphotericin B. The European Medicines Agency has twice refused to grant marketing authorization for Mycograb, citing product safety and quality issues.Chemically, efungumab is a single-chain variable fragment of a human monoclonal antibody.As such, it potentially act similarly to an IgA - inhibiting by binding and blocking.Its ability to potentiate the effects of the antifungal amphotericin B in culture were later found to be non-specific.".
- Q3720273 atcPrefix "none".
- Q3720273 fdaUniiCode "BM86P708HW".
- Q3720273 wikiPageWikiLink Q12140.
- Q3720273 wikiPageWikiLink Q130146.
- Q3720273 wikiPageWikiLink Q273510.
- Q3720273 wikiPageWikiLink Q290671.
- Q3720273 wikiPageWikiLink Q3491700.
- Q3720273 wikiPageWikiLink Q412223.
- Q3720273 wikiPageWikiLink Q412555.
- Q3720273 wikiPageWikiLink Q422248.
- Q3720273 wikiPageWikiLink Q5.
- Q3720273 wikiPageWikiLink Q507154.
- Q3720273 wikiPageWikiLink Q640448.
- Q3720273 wikiPageWikiLink Q7444591.
- Q3720273 wikiPageWikiLink Q79453.
- Q3720273 atcPrefix "none".
- Q3720273 unii "BM86P708HW".
- Q3720273 type ChemicalSubstance.
- Q3720273 type Drug.
- Q3720273 type ChemicalObject.
- Q3720273 type Thing.
- Q3720273 type Q8386.
- Q3720273 comment "Efungumab (trade name Mycograb) is a drug developed by NeuTec Pharma (a subsidiary of Novartis), intended to treat invasive Candida infection in combination with amphotericin B.".
- Q3720273 label "Efungumab".